No new catalyst: CP is up about 1.8%, extending the earlier gain after its Oct. 28 third-quarter results. CPKC reported Q3 revenue of $3.01 billion and diluted EPS of $0.75, while several firms maintained positive ratings or raised targets after the release. The stock rose as the S&P 500 and Nasdaq fell sharply, leaving the move primarily company-specific.
No new catalyst: CP is up about 1.8%, extending the earlier gain after its Oct. 28 third-quarter results. CPKC reported Q3 revenue of $3.01 billion and diluted EPS of $0.75, while several firms maintained positive ratings or raised targets after the release. The stock rose as the S&P 500 and Nasdaq fell sharply, leaving the move primarily company-specific.